KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Restructuring Costs (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Restructuring Costs readings, the most recent being $49.0 million for Q1 2026.

  • On a quarterly basis, Restructuring Costs fell 50.0% to $49.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $312.0 million, a 30.36% decrease, with the full-year FY2025 number at $70.0 million, up 40.0% from a year prior.
  • Restructuring Costs hit $49.0 million in Q1 2026 for Thermo Fisher Scientific, up from $46.0 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $228.0 million in Q4 2024 to a low of $2.0 million in Q2 2022.
  • Median Restructuring Costs over the past 5 years was $77.0 million (2024), compared with a mean of $80.1 million.
  • Biggest five-year swings in Restructuring Costs: plummeted 85.71% in 2022 and later surged 5500.0% in 2023.
  • Thermo Fisher Scientific's Restructuring Costs stood at $55.0 million in 2022, then soared by 45.45% to $80.0 million in 2023, then soared by 185.0% to $228.0 million in 2024, then tumbled by 79.82% to $46.0 million in 2025, then rose by 6.52% to $49.0 million in 2026.
  • The last three reported values for Restructuring Costs were $49.0 million (Q1 2026), $46.0 million (Q4 2025), and $135.0 million (Q3 2025) per Business Quant data.